The Female Health Company 

(Public, NASDAQ:FHCO)   Watch this stock   
Find more results for AMEX:FHC

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin 9.33% 19.38%
Operating margin 21.34% 12.42%
EBITD margin - 13.27%
Return on average assets 18.25% 39.70%
Return on average equity 24.85% 56.33%
Employees 168 -

Address

515 North State Street Suite 2225
Chicago, IL 60654
United States - Map
+1-312-5959123 (Phone)
+1-800-7764636 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

The Female Health Company discussed on blogs

Ranking All U.S. Stocks by Weekly Performance - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - 22 hours ago

The Female Health Company discussions

  View all discussions »

Description

The Female Health Company (FHC) manufactures, markets and sells the female condom (FC), the only product approved by the United States Food and Drug Administration (FDA) under a woman's control, which provides dual protection against unintended pregnancy and sexually transmitted diseases (STDs), including human immunodeficiency virus/acquired immune deficiency syndrome HIV/AIDS. The product is sold or available through various channels in 116 countries. It is commercially marketed directly to consumers in 15 countries by various country specific partners, including in the United States, the United Kingdom, France, Brazil, India and Canada.

Officers and directors

O. B. Parrish
Chairman of the Board, Acting President, Chief Executive Officer
Age: 75
Bio & Compensation - Reuters
Donna Felch
Chief Financial Officer, Vice President
Age: 61
Bio & Compensation - Reuters
Jack Weissman
Vice President - Sales
Age: 61
Bio & Compensation - Reuters
Michael Pope
Vice President; General Manager of The Female Health Company (UK) Plc
Age: 51
Bio & Compensation - Reuters
Janet Lee
Controller
Age: 44
Bio & Compensation - Reuters
William R. Gargiulo Jr.
Secretary, Director
Age: 80
Bio & Compensation - Reuters
Mary Ann Leeper Ph.D.
Senior Strategic Adviser, Director
Age: 68
Bio & Compensation - Reuters
David R. Bethune
Director
Age: 68
Bio & Compensation - Reuters
Stephen M. Dearholt
Director
Age: 62
Bio & Compensation - Reuters
Michael R. Walton
Director
Age: 71
Bio & Compensation - Reuters